Menu

Checkpoint Therapeutics, Inc. CKPT

Full chart Compare
Set alert

Price alert · CKPT

All alert types
4.26 0.00 (+0.00%)

At closeMay 30, 2025, 4:00 PM EDT

4.24 Day range 4.26

52-week range unavailable

YTD
+33.12%
1 year
+132.79%

Revenue & Expenses

Revenue → Gross Profit: $41.00KGross Profit → Expenses: $41.00KExpenses → Selling, General & Admin: $20.06MExpenses → Research & Development: $36.15MExpenses → Other Expenses: $66.00KNet Loss → Expenses: $56.24MGross Profit$41.00KNet Loss$56.24MExpenses$56.28MSelling, General & Admin$20.06MResearch & Development$36.15MOther Expenses$66.00KRevenue$41.00K

Latest period ending Dec 31, 2024 · select a line to chart its full history

CKPT annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
41.00K103.00K192.00K268.00K1.07M
41.00K103.00K192.00K268.00K1.07M
-56.17M-52.15M-58.33M-56.72M-23.20M
-56.24M-51.85M-62.62M-56.67M-23.08M
-1.42-3.17-7.09-7.45-4.10
CKPT annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
6.60M4.93M12.07M54.73M40.77M
7.47M5.38M13.29M55.73M42.60M
20.10M18.43M32.77M25.98M7.22M
-12.63M-13.05M-19.48M29.75M35.38M
CKPT annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-31.10M-47.59M-57.55M-26.31M-16.55M
32.78M40.45M14.89M40.27M31.25M
1.68M-7.14M-42.67M13.96M14.70M